Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus

The biguanide, metformin, is considered first-line treatment for type 2 diabetes. Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor acts through the incretin pathway and has a glucose dependent mode of action. The complementary hypoglycemic properties of these drugs make fixed dose combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballav, Chitrabhanu, Gough, Stephen C.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767579/
https://www.ncbi.nlm.nih.gov/pubmed/24031162
http://dx.doi.org/10.4137/CMED.S7314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767579/
https://www.ncbi.nlm.nih.gov/pubmed/24031162
http://dx.doi.org/10.4137/CMED.S7314

Ejemplares similares